01.10.2010 | Research Articles
Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain
Erschienen in: Clinical and Translational Oncology | Ausgabe 10/2010
Einloggen, um Zugang zu erhalten